Clinical utility of plasma Epstein‐Barr virus DNA and ERCC1 single nucleotide polymorphism in nasopharyngeal carcinoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|121|16|2720-2729

ISSN： 0008-543x

Source： CANCER, Vol.121, Iss.16, 2015-08, pp. : 2720-2729

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of plasma Epstein‐Barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high‐risk populations in Southern China

By  

CANCER, Vol. 120, Iss. 9, 2014-05 ,pp. : 1353-1360

John Wiley & Sons Inc

Access to resources Recommend Favorite

A Novel Application of Plasma and Cerebrospinal Fluid Level of Epstein Barr Virus DNA in the Diagnosis of Leptomeningeal Metastasis from Nasopharyngeal Carcinoma

By  

Oncology, Vol. 74, Iss. 1-2, 2008-06 ,pp. : 119-122

Karger

Access to resources Recommend Favorite

Epstein-Barr virus oncoprotein LMP1 mediates survivin upregulation by p53 contributing to G1/S cell cycle progression in nasopharyngeal carcinoma

By                

International Journal of Molecular Medicine, Vol. 29, Iss. 4, 2012-01 ,pp. : 574-580

Spandidos Publications

Access to resources Recommend Favorite

Genotypic Analysis of Epstein-Barr Virus Isolates Associated with Nasopharyngeal Carcinoma in Northern China

By  

Intervirology, Vol. 54, Iss. 3, 2010-10 ,pp. : 131-138

Karger

Access to resources Recommend Favorite

Reply to Genomic profiles of nasopharyngeal carcinoma: The importance of histological subtyping and Epstein‐Barr virus in situ assays

By  

CANCER, Vol. 124, Iss. 2, 2018-01 ,pp. : 435-436

John Wiley & Sons Inc

Access to resources Recommend Favorite